Let’s face it. Demand volatility, geopolitical uncertainty and changing regulations are placing pressure on every supply chain.
But Life Sciences companies also face mounting challenges in securing materials, controlling costs, and operating sustainably and transparently. They must ensure real-time compliance, maintain end-to-end quality control and manage multiple tiers of suppliers. With the rise of biologics and personalized medicine, more specialty contract manufacturers, cold-temperature logistics providers and other new partners are joining the supply chain network.
Life Sciences products are essential to patients and medical teams worldwide—but it’s getting more and more difficult to deliver them reliably and profitably in light of all these challenges.
Blue Yonder has created an on-demand webinar that discusses proven solutions, strategies and best practices for managing these challenges. “Achieving Real-Time Multi-Enterprise Collaboration and Compliance in Complex Supply Networks” reveals a central truth: For Life Sciences companies, supply chain optimization must occur at the network level.
Think about it. Of all the disruptions that occur daily across a typical Life Sciences supply chain—which spans thousands of miles and involves dozens of suppliers and trading partners—very few originate within the four walls of the manufacturing enterprise. And the vast majority of disruptions can’t be resolved by a single organization, acting alone.
When there’s a material shortage or a missed customer delivery, the problem occurs at a supplier node—and it can only be addressed via a collaborative resolution, like finding a new source of supply or an alternate carrier. When a regional health emergency, extreme weather event, new regulation or other external force acts on the supply network, collaboration is also required.
The modern Life Sciences supply chain faces a constant, unrelenting barrage of disruptions and exceptions. To operate profitability, it must be built to flex under that pressure and not break. It’s not enough to arrive at a collaborative decision—all stakeholders must also execute that decision quickly, in an orchestrated manner.
But most Life Sciences companies are trying to establish real-time visibility, collaboration and responsiveness across the network with manual, siloed processes, disconnected systems, and isolated planning and execution workflows. They simply can’t keep up with the complexity and fast-moving nature of today’s Life Sciences landscape. The results include high costs, low margins, lost sales, constrained revenues, compliance issues and product waste.
